ATAIのニュース
Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts 2023/03/06 17:27:13 InvestorPlace
The psychedelic drug boom may be taking off, but one company in the space is trimming its workforce. Atai Life Sciences (NASDAQ: ATAI ) just announced it has laid off roughly 30% of its staff. Shares are rising today, but it’s been a very difficult year for this penny stock. After declining more than 62% over the past six months, ATAI stock needs a positive catalyst to turn things around. This is likely part of the reason behind the Atai layoffs, which follow the company’s promise to implement a “company-wide cost optimization” initiative, a measure that hasn’t yet yielded the intended results. Let’s examine the company’s recent announcement and see what investors should be expecting as Atai prepares to hopefully turn a new corner. Atai Layoffs: A Closer Look Part of ATAI stock’s negative performance can be attributed to some poor clinical trial results. The company began the year by announcing disappointing news regarding a Phase 2 trial for PCN-101 (R-ketamine) as a means of addressing treatment-resistant depression.
Atai stock rises amid restructuring with ~30% job cuts 2023/03/06 12:44:23 Seeking Alpha
Atai Life Sciences (ATAI) has reduced its workforce by ~30% as part of a strategic review and also provided other clinical and corporate updates.Atai noted that the decision to…
atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference 2023/03/01 21:01:00 GlobeNewswire
NEW YORK and BERLIN, March 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Cowen 43rd Annual Health Care Conference.
The Atai Life Sciences N.V. (ATAI) had a good session last reading, didn’t it? 2023/02/28 16:16:00 US Post News
In Monday’s session, Atai Life Sciences N.V. (NASDAQ:ATAI) marked $1.66 per share, up from $1.62 in the previous session. While Atai Life Sciences N.V. has overperformed by 2.47%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ATAI fell by -69.37%, with highs and lows ranging from […]
Psychedelic Stock Gainers And Losers From February 21, 2023 2023/02/21 21:30:06 Benzinga
GAINERS: Cybin (AMEX: CYBN ) shares closed up 9.60% at $0.47 LOSERS: ATAI Life Sciences (NASDAQ: ATAI ) shares closed down 8.47% at $1.73 GH Research (NASDAQ: GHRS ) shares closed … Full story available on Benzinga.com